Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are the most maturely made TPD strategies. In this critique, we target both preclinical experiments and medical trials to deliver a comprehensive summary of the protection and scientific usefulness of PROTACs and MGDs in hematologic malignancies in the last two decades. Moreover, https://scottx863otx7.thecomputerwiki.com/user